The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA

Otitis media (OM) is a leading cause of pediatric antibiotic use. Introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) led to reductions in OM among US children, though its impact on OM-related antibiotic use remains unclear. Among 499 683 Tennessee children <2 years of age, the O...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffith, Hannah, Wiese, Andrew D, Mitchel, Edward F, Grijalva, Carlos G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843080/
https://www.ncbi.nlm.nih.gov/pubmed/35174252
http://dx.doi.org/10.1093/ofid/ofac019
_version_ 1784651177104769024
author Griffith, Hannah
Wiese, Andrew D
Mitchel, Edward F
Grijalva, Carlos G
author_facet Griffith, Hannah
Wiese, Andrew D
Mitchel, Edward F
Grijalva, Carlos G
author_sort Griffith, Hannah
collection PubMed
description Otitis media (OM) is a leading cause of pediatric antibiotic use. Introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) led to reductions in OM among US children, though its impact on OM-related antibiotic use remains unclear. Among 499 683 Tennessee children <2 years of age, the OM-related antibiotic fill rate was stable after PCV13 introduction.
format Online
Article
Text
id pubmed-8843080
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88430802022-02-15 The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA Griffith, Hannah Wiese, Andrew D Mitchel, Edward F Grijalva, Carlos G Open Forum Infect Dis Brief Report Otitis media (OM) is a leading cause of pediatric antibiotic use. Introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) led to reductions in OM among US children, though its impact on OM-related antibiotic use remains unclear. Among 499 683 Tennessee children <2 years of age, the OM-related antibiotic fill rate was stable after PCV13 introduction. Oxford University Press 2022-02-14 /pmc/articles/PMC8843080/ /pubmed/35174252 http://dx.doi.org/10.1093/ofid/ofac019 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Report
Griffith, Hannah
Wiese, Andrew D
Mitchel, Edward F
Grijalva, Carlos G
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA
title The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA
title_full The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA
title_fullStr The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA
title_full_unstemmed The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA
title_short The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA
title_sort impact of the 13-valent pneumococcal conjugate vaccine on otitis media–related antibiotic use among young children in tennessee, usa
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843080/
https://www.ncbi.nlm.nih.gov/pubmed/35174252
http://dx.doi.org/10.1093/ofid/ofac019
work_keys_str_mv AT griffithhannah theimpactofthe13valentpneumococcalconjugatevaccineonotitismediarelatedantibioticuseamongyoungchildrenintennesseeusa
AT wieseandrewd theimpactofthe13valentpneumococcalconjugatevaccineonotitismediarelatedantibioticuseamongyoungchildrenintennesseeusa
AT mitcheledwardf theimpactofthe13valentpneumococcalconjugatevaccineonotitismediarelatedantibioticuseamongyoungchildrenintennesseeusa
AT grijalvacarlosg theimpactofthe13valentpneumococcalconjugatevaccineonotitismediarelatedantibioticuseamongyoungchildrenintennesseeusa
AT griffithhannah impactofthe13valentpneumococcalconjugatevaccineonotitismediarelatedantibioticuseamongyoungchildrenintennesseeusa
AT wieseandrewd impactofthe13valentpneumococcalconjugatevaccineonotitismediarelatedantibioticuseamongyoungchildrenintennesseeusa
AT mitcheledwardf impactofthe13valentpneumococcalconjugatevaccineonotitismediarelatedantibioticuseamongyoungchildrenintennesseeusa
AT grijalvacarlosg impactofthe13valentpneumococcalconjugatevaccineonotitismediarelatedantibioticuseamongyoungchildrenintennesseeusa

Ejemplares similares